INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 155 filers reported holding INARI MED INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,264,000 | +349.9% | 80,489 | +300.0% | 0.01% | +600.0% |
| Q2 2023 | $1,170,000 | -95.3% | 20,122 | -95.0% | 0.00% | -96.6% |
| Q1 2023 | $24,825,000 | -78.5% | 402,093 | -77.8% | 0.03% | -78.7% |
| Q4 2022 | $115,352,000 | -37.2% | 1,814,852 | -28.2% | 0.14% | -39.6% |
| Q3 2022 | $183,670,000 | -6.4% | 2,527,995 | -12.4% | 0.22% | +2.3% |
| Q2 2022 | $196,201,000 | -25.7% | 2,885,730 | -0.9% | 0.22% | +9.5% |
| Q1 2022 | $263,945,000 | +0.7% | 2,912,019 | +1.4% | 0.20% | -7.8% |
| Q4 2021 | $262,060,000 | +19.4% | 2,871,262 | +6.1% | 0.22% | +16.6% |
| Q3 2021 | $219,513,000 | -8.9% | 2,706,695 | +4.8% | 0.19% | -5.6% |
| Q2 2021 | $240,846,000 | +15.2% | 2,581,965 | +32.1% | 0.20% | -33.1% |
| Q1 2021 | $209,094,000 | +337.8% | 1,954,154 | +257.2% | 0.30% | +322.9% |
| Q4 2020 | $47,755,000 | +1355.1% | 547,083 | +1050.3% | 0.07% | +1066.7% |
| Q3 2020 | $3,282,000 | +7.1% | 47,558 | -24.8% | 0.01% | +20.0% |
| Q2 2020 | $3,064,000 | – | 63,246 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |